After taking time to calm down, digest, and review the past
After taking time to calm down, digest, and review the past few days I've come to the realization that this was all done on purpose by Gerald and the team at AMBS. Think about it. Gerald stated that one of his main goal was to get the KOL's on board at Copenhagen. He continued that theme leading up to the U. N. Summit. He said he'd share data that would show how great Lympro was. He never said how he would release that data. Meaning we saw p values when we all assumed we would get S&S percentages. I believe after further review we can all agree that the numbers are in fact great as he eluded they'd be.
The bigger question for me was why they did it this way? I expect to see nothing but 1-8% gains a day for the next couple of weeks. If I had to guess, the partnership was decided once the p value shown to our partner. It probably gave AMBS the leverage to command more upfront $$$ and lower their % of royalties to said partner. Once the partner was decided the decision to not make all the data public yet was made. All in all, AMBS showed their hand with out having to show their hand getting better value for the long term SP and helping their partner so they can gobble up more shares before the announent is made public. I fully expect this large institution to be buying from now on in a controlled manner so as to not drive the share price up to quickly.
Would the head of marketing that led Amgen really allow Gerald to shoot himself in the foot with out? Comon....this was all or planned. My stops were hit between .16-.15 after some very nice gains. I promise you this, I will gobble up a lot more shares tomorrow. It all makes sense to me now. I never lost faith in the science, I just couldn't make sense of the past couple of weeks. Now I have. Best of luck to all. Don't be surprised if announcements come sooner than we expected and were told.
All imo
Amarantus Bioscience Holdings (AMBS) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...
Continue Reading
Digestive Wellness: The Emerging Opportunity Some days, it feels like everybody's got a gripe about their gut. You nod along at the lunch counter, folks buzzing about digestive this and acid that. But when PureHealth Research pops up with their fancy supplements, well, even the stock market's noisier nonsense starts sounding a bit quieter. They're banking big on the...
Continue Reading
The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...
Continue Reading
The Rise of "Safe Ground" on Prime Video This isn't your typical feel-good story—it’s about grit and the unending fight for 'normalcy' where war left scars. Safe Ground, now streaming on Prime Video, showcases Ryan Hendrickson, a U.S. Army Green Beret whose story takes a sharp turn after stepping on an IED in 2010. The day he almost became just another statistic...
Continue Reading
Echoes from Berlin IFA 2026 in Berlin was a cacophony of innovation, as OneOdio wrapped up its showcase with a bang. Boasting interactive activities and live DJ sets, the event echoed OneOdio's drive to meld advanced audio technology with the pulsating needs of music pros and everyday listeners. You couldn’t miss the excitement in the air at Booth 217. Tech Unplugged:...
Continue Reading
Honoring Tradition and Service The good ol’ U.S. Postal Service is at it again, giving a tip of the hat to a slice of American military heritage. This time, they’re putting out a new stamp to celebrate the 150th anniversary of the U.S. Coast Guard Academy. And you know where they did the honors? Right there on Custom House Pier in New London, Connecticut, a place that...
Continue Reading
Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...
Continue Reading
Trouble Brews at D-Wave Quantum Smack in the middle of market chaos, D-Wave Quantum Inc. (NASDAQ: QBTS) seems to have hit a rather gnarly pothole. With disappointing revenue figures for Q2 of 2026—coming in at a measly $3.08 million, far below the expected range of $4.03 million to $4.08 million—investors have more than enough reasons to be irked. When the numbers...
Continue Reading
Preserving Our Natural Chompers Digging into the details of endodontic care, you realize how it's the unsung hero in the dental world. And let's face it, teeth don't get happier on their own when there's a problem on the inside. Dr. Christopher Joubert, a wiz on the endodontic front, spills the beans over at HelloNation about how essential these practices are in keeping...
Continue Reading
Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...
Continue Reading
Top 5 Most Recently Viewed Articles
Uber's Position in Autonomous Driving Technology Gary Black, Managing Director of The Future Fund LLC, shares insights on Uber Technologies Inc. (NYSE: UBER) and the evolving landscape of autonomous driving technology. He believes that as automated driving continues to advance, Uber stands to benefit more than any other ride-hailing company in the market. Understanding...
Continue Reading
Gilat Satellite Networks Captures Significant Orders for Connectivity Gilat Satellite Networks Ltd. (NASDAQ: GILT, TASE: GILT), a leader in satellite networking technology, has made news by securing more than $18 million in new orders specifically for its in-flight connectivity (IFC) solutions. This impressive achievement underscores the increasing demand for quality...
Continue Reading
A Wine Festival Tradition in Eastern China A captivating wine-themed cultural festival took place in Mengshan Town, Shanggao County, aiming to uplift the local wine industry. This annual event draws visitors from various regions, uniting them in a shared love for fine wines and cultural experiences. The air was filled with excitement as participants engaged in thrilling...
Continue Reading
Understanding Recent Transactions at Danske Bank A/S Danske Bank A/S has been actively engaging in its share buy-back program, as evident from its latest managerial transactions. This initiative allows shareholders greater confidence and highlights the bank's proactive approach in strengthening its share value. Significance of Managerial Transactions Transactions carried...
Continue Reading
Opus Technologies Forms Strategic Alliance for Payment Solutions Opus Technologies has just unveiled a major strategic partnership with a leading company in payment solutions. This collaboration is focused on enhancing payment network compliance solutions for clients who navigate an increasingly regulated landscape. The Power of Synergy This alliance between Opus...
Continue Reading
